Get the Stockscreener App
0.1477
3.94%
0.0056
After Hours:
.15
0.0023
+1.56%
BiomX Inc stock is traded at $0.1477, with a volume of 1.95M.
It is up +3.94% in the last 24 hours and down -19.25% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.1421
Open:
$0.1417
24h Volume:
1.95M
Relative Volume:
0.82
Market Cap:
$3.92M
Revenue:
-
Net Income/Loss:
$-47.68M
P/E Ratio:
-0.00592
EPS:
-24.9619
Net Cash Flow:
$-23.09M
1W Performance:
+6.72%
1M Performance:
-19.25%
6M Performance:
-97.66%
1Y Performance:
-98.50%
1-Day Range:
$0.1371
$0.1486
1-Week Range:
$0.13
$0.1486
52-Week Range:
$0.1192
$12.29
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.1477 | 3.71M | 0 | -47.68M | -23.09M | -24.96 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Biomx Stock Price Forecast. Should You Buy PHGE? - StockInvest.us
BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows - Yahoo Finance
BiomX to rebrand as Tessera Defense and Homeland Security By Investing.com - Investing.com South Africa
BiomX Inc. to Rename Itself Tessera Defense and Homeland Security Inc. and Change NYSE American Ticker to HLSQ - Quiver Quantitative
BiomX Inc. to Become Tessera Defense and Homeland Security Inc. - marketscreener.com
BiomX To Carry Out 1-for-10 Reverse Stock Split On September 9th, 2026 - Moomoo
BiomX Inc (PHGE) Stock Price, Quote, News & History - Benzinga
BiomxAnnounces One-For-Ten Reverse Stock Split Of Common StockSEC Filing - TradingView
BiomX to implement 1-for-10 reverse stock split, authorized shares cut to 150M - TradingView
BiomX (PHGE) Financial Update: Profit Per Share Falls Below Its Benchmark in the Latest Reading - vinanet.vn
BiomX (PHGE) Close: Ends Lower by 0.52% at $0.13 for the Current Session; Market Levels: Support at $0.12 and Resistance at $0.14 Frame the Range in the Available RecordRunaway Gap - dars.gov.et
Cystic Fibrosis Foundation now at 5% or less of BiomX (PHGE) - Stock Titan
BiomX (PHGE) Earnings Report: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Earnings: The Market Price Moves 2.19% Higher in Latest TradingEPS Revision Trend - vinanet.vn
BiomX (PHGE) Market: Posts a 0.74% Gain to $0.14 for the Current Session; Key Range: the Current Price Sits Inside the Supplied Technical Range in Latest TradingHigh Beta Stocks - vinanet.vn
BiomX Inc. 2Q 2026: Revenue $0.33M, Net loss $3.85M, EPS ($0.36) — 10-Q Summary - TradingView
BiomX (PHGE) pivots into defense while warning on survival - Stock Titan
BiomX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Biomx Inc (NYSE: PHGE) Share Price, PHGE Stock News, PHGE Share Price & Updates - Kalkine
BiomX (PHGE) Momentum: Ends Up by 1.47% at $0.14 in the Latest Reading; Levels - vinanet.vn
BiomX (PHGE) Earnings Comparison: The EPS Result Is Below Expectation on the Day; Post-Report Move: Shares Move 5.88% Down for the Current SessionAdjusted Earnings Analysis - dars.gov.et
BiomX (PHGE) Earnings Comparison: The EPS Result Is Below Expectation on the Day; Post-Report Move - dars.gov.et
BiomX Company Profile & Introduction - Moomoo
BiomX Inc. SEC Filing (Aug 14, 2026) - Stock Titan
BiomX Inc. (PHGE): Nantahala reports 7.13% beneficial stake in 730,551 shares - Stock Titan
symbol__ Stock Quote Price and Forecast - cnn.com
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site - The Manila Times
BiomX Inc. (PHGE) investors disclose 0.7% stake and warrant holdings - Stock Titan
PHGE Q4 2025 Earnings: 73.75% EPS Miss and No Revenue Deepen Investor ConcernsNegative Surprise Momentum - vinanet.vn
BiomX to acquire 10% stake in MEA Testing Systems, grants option for majority buyout - Investing.com
Form 8K Biomx Inc For: 11 August By Investing.com - Investing.com Nigeria
BiomX Buying 10% of MEA for $50,000 and 1.3M Shares; Option Through 2028 for Control - TradingView
Biomx Inc (PHGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BiomX acquires 10% stake in electric motor testing firm By Investing.com - Investing.com Australia
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems - The Manila Times
Exclusive License Lets BiomX Develop and Distribute Drone Testing Solutions - Stock Titan
BiomX acquires 10% stake in electric motor testing firm - Investing.com India
BiomX Inc. acquired 10% stake in MEA Motomova India Private Limited/M.E.A. Testing Systems Ltd. from Motomova Inc. for $0.29 million. - marketscreener.com
BiomX (PHGE) Holds $0.18 Support After Modest 1.41% GainExhaustion Gap - vinanet.vn
BiomX amends Zorronet acquisition note, to issue shares By Investing.com - Investing.com Nigeria
BiomX Amends $1.25M Note With Water IO; Extends to Nov. 1 and Issues 800,000 Shares - TradingView
BiomX Amends Zorronet Acquisition Promissory Note, Extends Water.IO Payment Schedule - Quiver Quantitative
BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms - marketscreener.com
BiomXMay Offer And Sell Up To $9.10 Million Of Common Stock Through WainwrightSEC Filing - TradingView
Biomx Inc (PHGE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomx Inc (PHGE) Cash Flow - TradingKey
BiomX Inc. (PHGE) Edges Higher on Light Trading: Support Holds at $0.18Momentum Stock Picks - dars.gov.et
Biomx Inc (PHGE) Balance Sheet - TradingKey
TradingKey - TradingKey
Biomx Inc (PHGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PHGE|Biomx Inc|Price:0.189|Chg%:-0.011 - TradingKey
Biomx Inc (PHGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
BiomX Inc Stock (PHGE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yeganeh Reuven | Director |
Mar 16 '26 |
Sale |
5.00 |
450,000 |
2,250,000 |
0 |
| Yeganeh Reuven | Director |
Mar 13 '26 |
Sale |
5.00 |
370,000 |
1,850,000 |
0 |
| Yeganeh Reuven | Director |
Mar 12 '26 |
Sale |
5.00 |
300,000 |
1,500,000 |
0 |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):